CHLORZOXAZONE
Chlorzoxazone Tablets, USP
1df6058b-7bf2-4246-9827-93fa023a5fd4
HUMAN PRESCRIPTION DRUG LABEL
Jun 9, 2023
Rising Pharma Holdings, Inc.
DUNS: 116880195
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CHLORZOXAZONE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
CHLORZOXAZONE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
CHLORZOXAZONE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Drug Labeling Information
DESCRIPTION SECTION
For Painful Musculoskeletal Conditions
PRESCRIBING INFORMATION
DESCRIPTION
Each 375 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 375 mg.
Each 500 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 500 mg.
Each 750 mg Chlorzoxazone tablet contains: Chlorzoxazone USP 750 mg.
Chemical Name: 5-Chloro-2-benzoxazolinone.
Structural Formula:
Molecular Formula: C7H4CINO2
Molecular Weight: 169.56
Chlorzoxazone USP is a white or practically white, practically odorless, crystalline powder. Chlorzoxazone is slightly soluble in water; sparingly soluble in alcohol, in isopropyl alcohol, and in methanol; soluble in solutions of alkali hydroxides and ammonia.
Inactive ingredients: anhydrous lactose, croscarmellose sodium, docusate sodium with sodium benzoate, magnesium stearate, microcrystalline cellulose and pregelatinized maize starch.
FDA approved dissolution test specifications differ from USP.